369 related articles for article (PubMed ID: 33638353)
1. Adherence to, and patient convenience of, prolonged-release tacrolimus in stable kidney and liver transplant recipients after conversion from immediate-release tacrolimus in routine clinical practice in Switzerland.
Bonani M; Balaphas A; Bedino G; Bühler L; Dutkowski P; Fausch K; Gluderer S; Graf N; Hirt-Minkowski P; Müllhaupt B; Schönholzer C; Schulz MM; Venzin R; Wüthrich RP
Swiss Med Wkly; 2021 Feb; 151():w20453. PubMed ID: 33638353
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of adherence and tolerability of prolonged-release tacrolimus (Advagraf™) in kidney transplant patients in Germany: A multicenter, noninterventional study.
Lehner LJ; Reinke P; Hörstrup JH; Rath T; Suwelack B; Krämer BK; Budde K; Banas B
Clin Transplant; 2018 Jan; 32(1):. PubMed ID: 29052906
[TBL] [Abstract][Full Text] [Related]
3. Adherence of Renal Transplant Recipients to Once-daily, Prolonged-Release and Twice-daily, Immediate-release Tacrolimus-based Regimens in a Real-life Setting in Sweden.
Fellström B; Holmdahl J; Sundvall N; Cockburn E; Kilany S; Wennberg L
Transplant Proc; 2018 Dec; 50(10):3275-3282. PubMed ID: 30577197
[TBL] [Abstract][Full Text] [Related]
4. A Multicenter, Prospective, Observational Study of Conversion from Twice-Daily Immediate-Release to Once-Daily Prolonged-Release Tacrolimus in Liver Transplant Recipients in France: The COBALT Study.
Dumortier J; Duvoux C; Dubel L; Bazin F; Houssel-Debry P
Ann Transplant; 2019 Aug; 24():506-516. PubMed ID: 31451681
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety Evaluation After Conversion From Twice-Daily to Once-Daily Tacrolimus in Stable Liver Transplant Recipients: A Phase 4, Open-Label, Single-Center Study.
Kang WH; Song GW; Moon DB; Hwang S; Kim KH; Jung DH; Park GC; Yoon YI; Cho HD; Kim M; Kim SH; Na BG; Kim SM; Yang G; Lee SG
Transplant Proc; 2021 Dec; 53(10):3000-3006. PubMed ID: 34776265
[TBL] [Abstract][Full Text] [Related]
6. A Prospective, Observational Study of Conversion From Immediate- to Prolonged-Release Tacrolimus in Renal Transplant Recipients in France: The OPALE Study.
Moal V; Grimbert P; Beauvais A; Dubel L; Le Meur Y
Ann Transplant; 2019 Sep; 24():517-526. PubMed ID: 31477681
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of prolonged-release tacrolimus in stable pediatric allograft recipients converted from immediate-release tacrolimus - a Phase 2, open-label, single-arm, one-way crossover study.
Rubik J; Debray D; Kelly D; Iserin F; Webb NJA; Czubkowski P; Vondrak K; Sellier-Leclerc AL; Rivet C; Riva S; Tönshoff B; D'Antiga L; Marks SD; Reding R; Kazeem G; Undre N
Transpl Int; 2019 Nov; 32(11):1182-1193. PubMed ID: 31325368
[TBL] [Abstract][Full Text] [Related]
8. Conversion of twice-daily to once-daily tacrolimus is safe in stable adult living donor liver transplant recipients.
Kim SH; Lee SD; Kim YK; Park SJ
Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):374-9. PubMed ID: 26256081
[TBL] [Abstract][Full Text] [Related]
9. An observational study evaluating tacrolimus dose, exposure, and medication adherence after conversion from twice- to once-daily tacrolimus in liver and kidney transplant recipients.
Bäckman L; Persson CA
Ann Transplant; 2014 Mar; 19():138-44. PubMed ID: 24637379
[TBL] [Abstract][Full Text] [Related]
10. Adherence of Renal Transplant Recipients to Once-daily, Prolonged-Release and Twice-daily, Immediate-release Tacrolimus-based Regimens in a Real-life Setting in Sweden.
Fellström B; Holmdahl J; Sundvall N; Cockburn E; Kilany S; Wennberg L
Transplant Proc; 2020 Dec; 52(10):3238-3245. PubMed ID: 33218668
[TBL] [Abstract][Full Text] [Related]
11. Conversion From Once-Daily Prolonged-Release Tacrolimus to Once-Daily Extended-Release Tacrolimus in Stable Liver Transplant Recipients.
Altieri M; Delaval G; Kimmoun E; Allaire M; Salamé E; Dumortier J
Exp Clin Transplant; 2018 Jun; 16(3):321-325. PubMed ID: 28697715
[TBL] [Abstract][Full Text] [Related]
12. Conversion to prolonged release tacrolimus formulation in stable kidney transplant recipients.
Wu SW; Tsai HC; Tsai PY; Hung TW; Chang HR; Lian JD
Swiss Med Wkly; 2013; 143():w13850. PubMed ID: 23986367
[TBL] [Abstract][Full Text] [Related]
13. Safety and Efficacy of Conversion to Once-Daily Tacrolimus from Twice-Daily Tacrolimus in Pediatric Liver Transplant Recipients.
An S; Lee S; Rhu J; Kim JM; Choi GS; Joh JW
J Pediatr Surg; 2023 Oct; 58(10):2054-2058. PubMed ID: 37277238
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of conversion from twice-daily tacrolimus (prograf) to once-daily prolonged-release tacrolimus (graceptor) in stable kidney transplant recipients.
Nakamura Y; Hama K; Katayama H; Soga A; Toraishi T; Yokoyama T; Kihara Y; Jojima Y; Konno O; Iwamoto H; Takeuchi H; Hirano T; Shimazu M
Transplant Proc; 2012 Jan; 44(1):124-7. PubMed ID: 22310595
[TBL] [Abstract][Full Text] [Related]
15. Safety of conversion from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in stable liver transplant recipients.
Comuzzi C; Lorenzin D; Rossetto A; Faraci MG; Nicolini D; Garelli P; Bresadola V; Toniutto P; Soardo G; Baroni GS; Adani GL; Risaliti A; Baccarani U
Transplant Proc; 2010 May; 42(4):1320-1. PubMed ID: 20534291
[TBL] [Abstract][Full Text] [Related]
16. Increased adherence eight months after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation.
Doesch AO; Mueller S; Akyol C; Erbel C; Frankenstein L; Ruhparwar A; Ehlermann P; Dengler TJ; Katus HA
Drug Des Devel Ther; 2013; 7():1253-8. PubMed ID: 24174870
[TBL] [Abstract][Full Text] [Related]
17. A switch from conventional twice-daily tacrolimus to once-daily extended-release tacrolimus in stable kidney transplant recipients.
Hatakeyama S; Fujita T; Yoneyama T; Yoneyama T; Koie T; Hashimoto Y; Saitoh H; Funyu T; Narumi S; Ohyama C
Transplant Proc; 2012 Jan; 44(1):121-3. PubMed ID: 22310594
[TBL] [Abstract][Full Text] [Related]
18. Renal Function and Patient-Reported Outcomes in Stable Kidney Transplant Patients Following Conversion From Twice-Daily Immediate-Release Tacrolimus to Once-Daily Prolonged-Release Tacrolimus: A 12-Month Observational Study in Routine Clinical Practice in Germany (ADAGIO).
Hugo C; Weihprecht H; Banas B; Schröppel B; Jank S; Arns W; Schenker P; Rath T; Hergesell O; Feldkamp T; Hermann B; Schiffer M
Transplant Proc; 2021 Jun; 53(5):1484-1493. PubMed ID: 33610306
[TBL] [Abstract][Full Text] [Related]
19. Once daily tacrolimus conversion in lung transplantation: A prospective study on safety and medication adherence.
Godinas L; Dobbels F; Hulst L; Verbeeck I; De Coninck I; Berrevoets P; Schaevers V; Yserbyt J; Dupont LJ; Verleden SE; Vanaudenaerde BM; Ceulemans LJ; Van Raemdonck DE; Neyrinck A; Verleden GM; Vos R
J Heart Lung Transplant; 2021 Jun; 40(6):467-477. PubMed ID: 33840608
[TBL] [Abstract][Full Text] [Related]
20. Safety and Effectiveness of Conversion From Cyclosporine to Once-Daily Prolonged-Release Tacrolimus in Stable Kidney Transplant Patients: A Multicenter Observational Study in Japan.
Usuki S; Uno S; Sugamori H; Tanaka H; Aikawa A
Transplant Proc; 2018 Dec; 50(10):3266-3274. PubMed ID: 30577196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
